Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

VITATRACE

K-Number: K893425 · 1989-07-14

ApplicantLectec Corp.
Decision Date1989-07-14
Product CodeDRX
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

VITATRACE is the device name listed in this FDA 510(k) record. The listed applicant is Lectec Corp.. It received FDA 510(k) clearance on 1989-07-14 under 510(k) number K893425. The device is classified under product code DRX. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the VITATRACE?

VITATRACE is a medical device that received FDA 510(k) clearance on 1989-07-14. The listed applicant is Lectec Corp.. The 510(k) number is K893425.

When did VITATRACE receive FDA 510(k) clearance?

VITATRACE received FDA 510(k) clearance on 1989-07-14, under 510(k) number K893425.

Who is the listed applicant for VITATRACE?

The FDA 510(k) record lists Lectec Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for VITATRACE?

The FDA product code for VITATRACE is DRX.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Lectec Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 27 devices →

Related Devices (Code: DRX)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑